Essex, United Kingdom

Paul Winship

USPTO Granted Patents = 5 

Average Co-Inventor Count = 8.8

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Harlow, GB (2017 - 2018)
  • Essex, GB (2018 - 2021)

Company Filing History:


Years Active: 2017-2021

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Paul Winship: Innovator in Pharmaceutical Modulation

Introduction

Paul Winship is a notable inventor based in Essex, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate RORc, a receptor involved in various inflammatory diseases. With a total of 5 patents to his name, Winship's work is paving the way for new treatment options.

Latest Patents

Among his latest patents, Winship has developed pyridazine derivatives as RORc modulators. These compounds, along with their pharmaceutical salts, are designed to treat inflammatory diseases such as arthritis. Another significant patent involves aryl sultam derivatives, which also serve as RORc modulators. These compounds are aimed at treating not only arthritis but also muscular sclerosis and psoriasis.

Career Highlights

Winship is currently employed at Genentech, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on creating effective treatments for chronic inflammatory conditions, showcasing his commitment to improving patient outcomes.

Collaborations

Throughout his career, Winship has collaborated with talented individuals such as Benjamin Fauber and Emanuela Gancia. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Paul Winship's contributions to pharmaceutical innovation are noteworthy, particularly in the realm of inflammatory disease treatment. His ongoing work at Genentech, Inc. and his impressive portfolio of patents highlight his role as a leading inventor in this critical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…